Article

Breakthrough infection elicits hypermutated IGHV3-53/3-66 public antibodies with broad and…

bioRxiv: the preprint server for biology · 2023 · Ling Li, author Xixian Chen, author Zuowei Wang, author Yunjian Li, author Chen Wang, author Liwei Jiang, author Teng Zuo, author

Key facts

Title Breakthrough infection elicits hypermutated IGHV3-53/3-66 public antibodies with broad and potent neutralizing activity against SARS-CoV-2 variants including BQ and XBB lineages
First author Ling Li, author Xixian Chen, author Zuowei Wang, author Yunjian Li, author Chen Wang, author Liwei Jiang, author Teng Zuo, author
Journal bioRxiv : the preprint server for biology
Published Jul 23, 2023
DOI 10.1101/2023.07.18.549524
Devices mentioned K843077, K843710
Product codes mentioned DGC, LGC, MVU

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature